News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Alaris Medical, Inc. (AMI) Elects Jacqueline Kosecoff To Board Of Directors

10/19/2005 5:09:31 PM

SAN DIEGO--(BUSINESS WIRE)--Dec. 12, 2003--ALARIS Medical Systems Inc. (NYSE: AMI - News) today announced that Jacqueline Kosecoff, Ph.D., has been elected to serve as a member of its Board of Directors. Dr. Kosecoff is executive vice president, Pharmaceutical Services at PacifiCare Health Systems Inc. (NYSE: PHS - News), one of the nation's largest consumer health organizations. Prior to joining PacifiCare, Dr. Kosecoff was founder, president and chief operating officer of Protocare (now Constella Health Strategies and Radiant Research), a firm whose lines of business included the clinical development of drugs, devices, biopharmaceutical and nutritional products and health services consulting. Dr. Kosecoff was co-founder and co-CEO of Value Health Sciences (VHS), a wholly owned subsidiary of Value Health Inc. (NYSE: VHI - News). VHS was the first company to combine medical sciences and information technology to reengineer the utilization review and approval process, and sent on to introduce sophisticated systems that brought health services data into management's use.

Dr. Kosecoff is a recognized expert in the areas of clinical and health services research, quality of care and technology assessment, disease management and organization of the health care delivery system. She served as Professor of Medicine and Public Health at the University of California, Los Angeles, where she still holds a Research Professorship. She has published extensively in such journals as the New England Journal of Medicine, Journal of the American Medical Association and the Annals of Internal Medicine.

"Jackie is an excellent addition to our Board," said David L. Schlotterbeck, president and chief executive officer. "Her skills and experience with both the medical community and the hospital and healthcare systems' information technology environments will bring valuable perspectives to our Board as we continue our commitment to deliver practical solutions for intravenous medication safety at the critical point of care."

Dr. Kosecoff has also served as a consultant to the World Health Organization's Global Quality Assessment Programs, on the Institute of Medicine's Board of Health Care Services and the RAND Graduate School's Board of Governors. Currently, Dr. Kosecoff sits on the board of directors for the City of Hope, Pharmaceutical Care Management Association (PCMA) and STERIS Corp. (NYSE: STE - News).

Dr. Kosecoff holds a BA from the University of California, Los Angeles, an MS in Applied Mathematics from Brown University, and a doctorate in Research Methods from the University of California, Los Angeles.

Her election expands the ALARIS Medical Systems Inc. Board of Directors from six to seven members.

About ALARIS Medical Systems Inc.

ALARIS Medical Systems Inc. (NYSE: AMI - News) develops and markets products for the safe delivery of intravenous (IV) medications. The company's IV medication and infusion therapy delivery systems, software applications, needle-free disposables and related monitoring equipment are marketed in the United States and internationally. ALARIS Medical Systems' "smart" pumps, with the proprietary GuardrailsĀ® Safety Software, help to reduce the risks and costs of medication errors, help to safeguard patients and clinicians and gather and record clinical information for review, analysis and interpretation. The company provides its products, professional and technical support and training services to over 5,000 hospital and health care systems, as well as alternative care sites, in more than 120 countries through its direct sales force and distributors. With headquarters in San Diego, ALARIS Medical Systems employs approximately 2,900 people worldwide. Additional information on ALARIS Medical Systems can be found at


ALARIS Medical Systems Inc., San Diego William C. Bopp, 858-458-7994

Source: ALARIS Medical Systems Inc.

Read at

comments powered by Disqus